JPMORGAN CHASE & CO - Mar 31, 2025 Form SCHEDULE 13G/A Schedule Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: REGENERON PHARMACEUTICALS, INC. Common Stock - par value $.001 per share
Symbol: REGN
Shares outstanding: 109M shares
Disclosed Ownership: 5.55M shares
Ownership: 5.1%
Form type: SCHEDULE 13G/A
Date filed: 4/22/2025, 12:01 PM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	5.1%	5.55M	4.88M	30.7K	Rachel Tsvaygoft	Vice President